HU188742B - Process for producing substituted 3,4-diamni-1,2,5-thiadiazoles and pharmaceutical compositions of hystamine-h2-receptor antagonistic aczivity containing them as active agents - Google Patents

Process for producing substituted 3,4-diamni-1,2,5-thiadiazoles and pharmaceutical compositions of hystamine-h2-receptor antagonistic aczivity containing them as active agents Download PDF

Info

Publication number
HU188742B
HU188742B HU831040A HU104083A HU188742B HU 188742 B HU188742 B HU 188742B HU 831040 A HU831040 A HU 831040A HU 104083 A HU104083 A HU 104083A HU 188742 B HU188742 B HU 188742B
Authority
HU
Hungary
Prior art keywords
formula
compound
methyl
amino
pharmaceutically acceptable
Prior art date
Application number
HU831040A
Other languages
English (en)
Hungarian (hu)
Inventor
Crenshaw
Algieri
Original Assignee
Bristol-Myers Co,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Co,Us filed Critical Bristol-Myers Co,Us
Publication of HU188742B publication Critical patent/HU188742B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU831040A 1982-03-29 1983-03-28 Process for producing substituted 3,4-diamni-1,2,5-thiadiazoles and pharmaceutical compositions of hystamine-h2-receptor antagonistic aczivity containing them as active agents HU188742B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (1)

Publication Number Publication Date
HU188742B true HU188742B (en) 1986-05-28

Family

ID=23429274

Family Applications (2)

Application Number Title Priority Date Filing Date
HU831040A HU188742B (en) 1982-03-29 1983-03-28 Process for producing substituted 3,4-diamni-1,2,5-thiadiazoles and pharmaceutical compositions of hystamine-h2-receptor antagonistic aczivity containing them as active agents
HU854071A HU196386B (en) 1982-03-29 1983-03-28 Process for production of derivatives of substituated ethan-diimid-amid

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU854071A HU196386B (en) 1982-03-29 1983-03-28 Process for production of derivatives of substituated ethan-diimid-amid

Country Status (30)

Country Link
JP (2) JPS58180477A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880002209B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT386599B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU557577B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE896291A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH655111A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (2) CS250229B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (2) DD219768A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3311281A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK166677B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (3) ES8404683A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2542741B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB2117769B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR78524B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU188742B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE55596B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL68259A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1164633B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU84716A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8700942A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8301063A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO163055C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ203726A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA07356A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT76459B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (2) SE461040B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (2) SU1419518A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU44849B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA832154B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZW (1) ZW7683A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
FI76795C (fi) * 1979-09-04 1988-12-12 Bristol Myers Co Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter.
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
GR78524B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-27
NL8301063A (nl) 1983-10-17
OA07356A (fr) 1984-08-31
KR840004095A (ko) 1984-10-06
AU557577B2 (en) 1986-12-24
YU44849B (en) 1991-04-30
JPH0568472B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-09-29
AU6327286A (en) 1987-01-08
GB2149406A (en) 1985-06-12
AU1290783A (en) 1983-10-06
DK81192A (da) 1992-06-18
FR2542741B1 (fr) 1989-12-08
SE464302B (sv) 1991-04-08
ES520982A0 (es) 1984-05-16
YU74483A (en) 1986-02-28
SE8301725L (sv) 1983-11-25
FR2597867B1 (fr) 1989-12-08
GB8432809D0 (en) 1985-02-06
IT8348005A0 (it) 1983-03-28
ES8404683A1 (es) 1984-05-16
IL68259A0 (en) 1983-06-15
CS250229B2 (en) 1987-04-16
NO163055B (no) 1989-12-18
BE896291A (fr) 1983-09-28
FR2597867A1 (fr) 1987-10-30
ES527685A0 (es) 1985-06-16
ATA111083A (de) 1988-02-15
AU586037B2 (en) 1989-06-29
FR2542741A1 (fr) 1984-09-21
ES8505978A1 (es) 1985-06-16
CH660880A5 (de) 1987-05-29
NO831100L (no) 1983-09-30
ES527686A0 (es) 1985-06-16
SE8704689D0 (sv) 1987-11-25
GB2117769B (en) 1985-08-29
IE830686L (en) 1983-09-29
NZ203726A (en) 1986-05-09
IE55596B1 (en) 1990-11-21
DE3311281A1 (de) 1983-11-24
ZW7683A1 (en) 1984-01-04
GB2149406B (en) 1986-01-02
HU196386B (en) 1988-11-28
NO163055C (no) 1990-03-28
GB2117769A (en) 1983-10-19
SE8301725D0 (sv) 1983-03-28
SE8704689L (sv) 1987-11-25
PT76459B (en) 1986-03-11
MY8700942A (en) 1987-12-31
DD219768A5 (de) 1985-03-13
DD210909A5 (de) 1984-06-27
ZA832154B (en) 1983-12-28
IT1164633B (it) 1987-04-15
AT386599B (de) 1988-09-12
JPS58180477A (ja) 1983-10-21
SU1419518A3 (ru) 1988-08-23
DK141383A (da) 1983-09-30
SU1355123A3 (ru) 1987-11-23
SE461040B (sv) 1989-12-18
CS250240B2 (en) 1987-04-16
DK166677B1 (da) 1993-06-28
GB8308518D0 (en) 1983-05-05
ES8505977A1 (es) 1985-06-16
JPH06135925A (ja) 1994-05-17
CH655111A5 (de) 1986-03-27
KR880002209B1 (ko) 1988-10-18
PT76459A (en) 1983-04-01
DK141383D0 (da) 1983-03-28
DK81192D0 (da) 1992-06-18
LU84716A1 (fr) 1983-12-05

Similar Documents

Publication Publication Date Title
FI78695B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-diaminocyklobuten-3,4-dionderivat.
SU1400508A3 (ru) Способ получени производных арилтиазолов
DK162222B (da) 2-amino-5-hydroxy-4-methylpyrimidin-derivater og farmeceutiske praeparater indeholdende disse
IE840655L (en) 1,3-thiazolidine derivatives
KR830001920B1 (ko) 티아졸 유도체의 제조방법
HU198925B (en) Process for 3,4-diamino-1,2,5-thiadiazole derivatives
HU188742B (en) Process for producing substituted 3,4-diamni-1,2,5-thiadiazoles and pharmaceutical compositions of hystamine-h2-receptor antagonistic aczivity containing them as active agents
US4528375A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
HU182645B (en) Process for preparing n-cyano-n'-2-//4-methyl-5-imidazolyl/-methyl-thio/-ethyl-n''-alkinyl-guanidine
US4600779A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528377A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528378A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
HU192875B (en) Process for preparing 2-pyridinethiol derivatives
US4588826A (en) Ethanediimidamide intermediates
US4578471A (en) Substituted amino alkyl pyridyl ethanediimidamides
EP0452076B1 (en) Thiazole and imidazole derivatives and antiulcer composition containing same
US4517366A (en) Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
IE47543B1 (en) Guanidine derivatives
US4595758A (en) Ethanediimidamide intermediates
KR880002530B1 (ko) 치환된 에탄디이미드 아미드 및 그의 제조방법
CS257276B2 (en) Production method substituted 3,4-diamino-1,2,5thiadiazoles
CA1253144A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h.sub.2-receptor antagonist activity
NO157576B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tioalkylamid av nikotinsyre-1-oksyd.
NO880872L (no) Fremgangsmaate til fremstilling av en kjemisk forbindelse.

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee